A BioForward Milwaukee event to introduce an exciting field that has been gaining momentum in research, clinical practices, and the biohealth industry, the Microbiome. The event featured talks from industry and research experts, morning refreshments, and networking before and after the event!
Featured speakers included Steven Visuri and Karen Harrington from FloraSeq to discuss the basics of the Microbiome, and, to discuss their research into the Microbiome, Nita Salzman from the Medical College of Wisconsin and Children’s Research Institute and Sandra McLellan from the UW-Milwaukee School of Freshwater Sciences.
FloraSeq was founded in Waukesha, WI in 2014 to leverage the knowledge of the human microbiome. The founders are Steve Visuri and Karen Harrington who have over 40 years of experience in medical devices and diagnostics with senior leadership positions at Prodesse, Gen-Probe, and Hologic. Initially FloraSeq is focused on developing microbiota-based products, building on the success of fecal transplant, to treat recurrent Clostridium difficile (C. diff) infections. In parallel, FloraSeq is seeking to establish a CLIA Clinical Laboratory to perform complimentary diagnostic testing. Future opportunities include next-generation therapeutics for treating a variety conditions related to gut dysbiosis and expansion of laboratory test menu.
About Steven Visuri: Steven R. Visuri, PhD serves as President and CEO of FloraSeq, LLC. He was previously the Senior Director of Research and Development at Hologic. He was also Head of Business Development & Corporate Development and Chief Science Officer of Prodesse Inc. Dr. Visuri joined Prodesse in July 2003. Previously, he served as a Senior Research Scientist and Group Leader in the Medical Technology Program at Lawrence Livermore National Laboratory. He has worked extensively in the areas of clinical medicine and homeland security. Dr. Visuri has several patents issued and pending along with numerous journal articles and conference presentations in these areas of research. He received his Ph.D. and M.S. degrees from Northwestern University in Biomedical Engineering and his B.S. degree from Marquette University in Electrical Engineering.
About Karen Harrington: Karen Harrington, PhD, HCLD is the co-founder of FloraSeq, LLC. Previously, she worked as a Clinical Laboratory Manager at Gen-Probe Prodesse and went on to become the Senior Manager of Clinical Affairs for Hologic, Inc. She earned her Ph.D. in Molecular Genetics and Biochemistry from Georgia State University and a B.S. in Biology from Marquette University.
About Nita Salzman: Nita Salzman, MD, PhD is a Professor of Pediatrics at the Medical College of Wisconsin, Investigator at the Children’s Research Institute, and Director of the MCW Pediatric Gastroenterology and Nutrition Laboratory. Her lab is focused on understanding the complex bacterial ecosystem that lives in our intestinal tract and how it relates to nutrition, metabolism, and immune response. Her lab uses advanced techniques and both basic and translational studies to understand and study the MicroBiome, pediatric Crohn’s Disease, and pediatric non-alcoholic fatty liver disease. She has published numerous journal articles and has been invited to speak about the MicroBiome all over the world. She received her M.D. and Ph.D. from New York University School of Medicine and completed her residency in pathology at the Hospital of the University of Pennsylvania.
About Sandra McLellan: Sandra L. McLellan, PhD is a Professor and Senior Scientist at the UW-Milwaukee School of Freshwater Sciences. Her lab studies the connections between environmental effects and human health. She is interested in how sewage and pollution can affect the Great Lakes and the incidence of waterbourne diseases. She has been published many times on the link between the MicroBiome and the microbial communities found in freshwater pollution. She received her Ph.D. in Environmental Health from the University of Cincinnati and her B.S. in Health Sciences from UW-Milwaukee.
July 12, 2016
Quarles & Brady, LLP